Delivery Order SPE2DB24D3013-SPE2DB24FFGXT

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,787.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is a delivery order to supply 4565699684 TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of September 6, 2024. The contract is a Firm Fixed Price arrangement without any set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor to the U.S. government. The award, valued at $4,644.48, is a Firm Fixed Price Delivery Order for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of August 7, 2024 and does not have a set-aside designation. As a large pharmaceutical supplier,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $2,265.50, is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price delivery order, with a completion date of July 22, 2024. AmerisourceBergen, a major U.S. pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to supply a wide...
This federal contract award, valued at $3,430.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024 and does not have a set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor in the United States, has been awarded numerous federal contracts to...
This federal contract award, valued at $2,612.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The award has an ultimate completion date of August 27, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 20, 2024. This award is not associated with a set-aside program. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous federal contracts to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award, valued at $14,593.36, is a delivery order contract for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a firm fixed price and an ultimate completion date of July 29, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office Division, has...
This federal contract award, valued at $48,456.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with an ultimate completion date of October 15, 2024. The contract is a firm-fixed-price type with no set-aside designation. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award, valued at $4,324.93, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of July 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies...
This federal contract award, valued at $7,276.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFGXT
    Delivery Order

This federal contract award, valued at $6,104.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 15, 2024, and is a Delivery Order under a Firm Fixed Price contract type. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to supply a wide range of critical medical commodities, including specialty medications, generic drugs, and medical supplies, to support various government healthcare programs and military treatment facilities. The company's extensive supply chain capabilities and experience in servicing federal customers make it a key provider of essential pharmaceutical and medical products to the U.S. government.

Generated 11/13/24, 9:11 AM